/ Print /

Health Management

Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.
Here’s a more effective way to test for HPVA Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.
Ten ways multiple myeloma treatment is changingAs multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.
CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
‘Encouraging’ COPD drug pipeline could ease symptoms, address root causesAlbert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow address the underlying disease process.
Three ways to help nurses advance your population health initiativesWidespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.
Managing cancer treatment side effects: What payers should knowMoffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.
Health plans explore psychosocial support services to improve outcomesPatients who lack resources likely won’t have improved health outcomes even with interventions. Some plans are exploring how to address the problem.